News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
259,204 Results
Type
Article (13832)
Company Profile (293)
Press Release (245079)
Section
Business (79305)
Career Advice (147)
Deals (13176)
Drug Delivery (31)
Drug Development (50264)
Employer Resources (31)
FDA (5668)
Job Trends (5110)
News (144022)
Policy (10013)
Tag
Academia (901)
Alliances (21440)
Alzheimer's disease (731)
Approvals (5632)
Artificial intelligence (61)
Bankruptcy (97)
Best Places to Work (4468)
Biotechnology (241)
Breast cancer (57)
Cancer (603)
Cardiovascular disease (52)
Career advice (128)
CAR-T (48)
Cell therapy (156)
Clinical research (39607)
Collaboration (205)
Compensation (85)
COVID-19 (998)
C-suite (58)
Cystic fibrosis (61)
Data (641)
Diabetes (65)
Diagnostics (1191)
Earnings (28677)
Events (46602)
Executive appointments (157)
FDA (5917)
Funding (210)
Gene editing (51)
Gene therapy (130)
GLP-1 (292)
Government (1063)
Healthcare (6528)
Infectious disease (1028)
Inflammatory bowel disease (89)
IPO (7169)
Job creations (859)
Job search strategy (124)
Layoffs (182)
Legal (1372)
Lung cancer (102)
Manufacturing (68)
Medical device (2547)
Medtech (2548)
Mergers & acquisitions (6090)
Metabolic disorders (204)
Neuroscience (913)
NextGen Class of 2024 (1997)
Non-profit (842)
Northern California (810)
Obesity (117)
Opinion (90)
Parkinson's disease (55)
Patents (47)
People (24902)
Pharmaceutical (48)
Phase I (13924)
Phase II (18413)
Phase III (11689)
Pipeline (168)
Postmarket research (846)
Preclinical (5885)
Radiopharmaceuticals (203)
Rare diseases (144)
Real estate (1409)
Regulatory (8166)
Research institute (930)
Southern California (749)
Startups (1963)
United States (6793)
Vaccines (154)
Weight loss (74)
Date
Today (125)
Last 7 days (535)
Last 30 days (1931)
Last 365 days (20590)
2024 (17933)
2023 (22412)
2022 (26822)
2021 (27806)
2020 (23357)
2019 (16224)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (16771)
Australia (2821)
California (1839)
Canada (654)
China (137)
Colorado (70)
Connecticut (72)
Europe (36106)
Florida (198)
Georgia (53)
Illinois (113)
Indiana (53)
Kansas (54)
Maryland (278)
Massachusetts (1536)
Michigan (45)
Minnesota (83)
New Jersey (497)
New York (552)
North Carolina (384)
Northern California (810)
Ohio (73)
Pennsylvania (386)
South America (207)
Southern California (749)
Texas (192)
Washington State (199)
259,204 Results for "endonovo therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions
SofPulse Inc. -- a subsidiary of Endonovo (OTC PINK: ENDV) and a proposed spin-off company -- announced today the participation of its SofPulse® Pulsed Electro-Magnetic Field (PEMF) FDA-cleared medical device in the United States Army Medical Research and Development Command (USAMRDC) May 2024 Vendor Day.
March 4, 2024
·
6 min read
Biotech Beach
Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update
Endonovo Therapeutics Inc. is proud to announce a series of advancements in the first half of 2023.
August 8, 2023
·
7 min read
FDA
Endonovo’s SofPulse® Secures Taiwan FDA Approval
Endonovo Therapeutics, Inc. (OTCQB: ENDV) US-based medical device company, today announced the full regulatory approval of its flagship product, SofPulse® by the Taiwan Food and Drug Administration (TFDA), the regulatory division of the Ministry of Health and Welfare (MOHW).
October 12, 2023
·
6 min read
Biotech Beach
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
Endonovo Therapeutics, Inc. announced its inclusion on the Federal Supply Schedule for SofPulse® Pulsed Electro Magnetic Field medical devices for distribution throughout the Federal healthcare supply channels.
August 22, 2023
·
6 min read
Biotech Beach
Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan
Endonovo Therapeutics, Inc. (OTCQB: ENDV) -- a medical device company known for its innovative and effective pain management solutions -- announced today that it is entering the final stages of clearance to receive a Taiwan FDA (TFDA) License for Medical Devices to distribute its flagship product, SofPulse® in Taiwan.
March 23, 2023
·
5 min read
Biotech Beach
Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies
Endonovo Therapeutics, Inc. (OTCQB: ENDV), a leading developer of medical technologies, today announced it is moving forward in its clinical development in the field of Traumatic Brain Injury (TBI) treatment.
April 25, 2023
·
6 min read
Biotech Beach
Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg
Endonovo Therapeutics, Inc. (OTCQB: ENDV), a medical device company specializing in pulsed electromagnetic field (PEMF) technology, announced today it will hold a question and answer session for shareholders on March 9, 2023 at 4:30pm EST with Ira Weisberg, President of Endonovo’s Medical Division.
February 28, 2023
·
4 min read
Biotech Beach
Endonovo Partners with International Distributor for SofPulse® Line
Endonovo Therapeutics, Inc. announced a new non-exclusive stocking distributor agreement with Pulse Therapeutics Technology, Inc. to purchase and distribute its SofPulse® medical devices into Mexico and Costa Rica.
January 26, 2023
·
3 min read
Biotech Beach
Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off
Endonovo Therapeutics, Inc. announced the retention of Ocean Tomo, a part of J.S. Held, to conduct a fairness opinion analysis in connection with the proposed spin-off of Endonovo’s medical device assets to a newly formed Delaware company, SofPulse, Inc.
January 31, 2023
·
4 min read
Business
Endonovo Names Ira Weisberg President to Guide Global Medical Expansion
Endonovo Therapeutics, Inc. named Ira Weisberg as President and Chief Commercial Officer of its Medical Division.
November 30, 2022
·
6 min read
1 of 25,921
Next
